Abstract:Aims: Congenital heart disease (CHD) frequently occurs in newborns due to abnormal formation of the heart or major blood vessels. Mutations in the GATA4 gene, which encodes GATA binding protein 4, are responsible for atrial septal defect (ASD), a common CHD. This study aims to gain insights into the molecular mechanisms of CHD using human induced pluripotent stem cells (iPSCs) from a family cohort with ASD. Methods and Results: Patient-specific iPSCs possess the same genetic information as the donor and can differentiate into various cell types from all three germ layers in vitro , thus presenting a promising approach for disease modeling and molecular mechanism research. Here, we generated a patient-specific iPSC line (iPSC-G4 T280M ) from a family cohort carrying a hereditary ASD mutation in GATA4 gene (T280M), as well as a human embryonic stem cell line (ESC-G4 T280M ) carrying the isogenic T280M mutation using the CRISPR/Cas9 genome editing method. The GATA4-mutant iPSCs and ESCs were then differentiated into cardiomyocytes (CMs) to model GATA4 mutation-associated ASD. We observed an obvious defect in cell proliferation in cardiomyocytes derived from both GATA4 T280M -mutant iPSCs (iPSC-G4 T280M -CMs) and ESCs (ESC-G4 T280M -CMs), while the impaired proliferation ability of iPSC-G4 T280M -CMs could be restored by gene correction. Integrated analysis of RNA-Seq and ChIP-Seq data indicated that FGF16 is a direct target of wild-type GATA4. However, the T280M mutation obstructed GATA4 occupancy at the FGF16 promoter region, leading to impaired activation of FGF16 transcription. Overexpression of FGF16 in GATA4-mutant cardiomyocytes rescued the cell proliferation defect. The direct relationship between GATA4 T280M and ASD was demonstrated in a human iPSC model for the first time. Conclusions: In summary, our study revealed the molecular mechanism of the GATA4 T280M mutation in ASD. Understanding the roles of the GATA4-FGF16 axis in iPSC-CMs will shed light on heart development and provide novel insights for the treatment of ASD and other CHD disorders.

Molecular Mechanism Study on GATA-4 M310V Gene Mutation Involved in Patients With Familial Atrial Septal Defect

Involvement Of A Novel Gata4 Mutation In Atrial Septal Defects

A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect.

GATA4 Transgenic Mice As an in Vivo Model of Congenital Heart Disease.

The mutations ofGATA4andGATA6 in children with isolated atrial septal defect

A novel GATA-binding protein 4 gene variation associated with familial atrial septal defect

Genetic Screening for Novel GATA4 Mutations Associated with Congenital Atrial Septal Defect

Identification of the novel GATA6 mutation associated with congenital atrial septal defect

Mutation analysis of GATA4 gene in Han Chinese patients with atrioventricular septal defect

A mutation in the Kozak sequence of GATA4 hampers translation in a family with atrial septal defects

Abstract P305: Patient-specific Ipsc-derived Cardiomyocytes Reveal Abnormal Regulation Of Fgf16 In A Familial Atrial Septal Defect

The Study on GATA4 Gene Mutationsin Chinese Patients with Congenital Heart Disease

Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.

A Novel GATA4 Loss-of-Function Mutation Associated with Congenital Ventricular Septal Defect

GATA4 loss-of-function mutations in familial atrial fibrillation.

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

Novel Gata4 Mutations In Lone Atrial Fibrillation

Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect

Mutation P.s335x in GATA4 Reduces Its DNA Binding Affinity and Enhances Cell Apoptosis Associated with Ventricular Septal Defect

A Novel Missense Mutation Of Gata4 In A Chinese Family With Congenital Heart Disease

A gain-of-function ACTC1 3′UTR mutation that introduces a miR-139-5p target site may be associated with a dominant familial atrial septal defect